"Luteolin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
5,7,3',4'-tetrahydroxy-flavone, one of the FLAVONES.
Descriptor ID |
D047311
|
MeSH Number(s) |
D03.383.663.283.266.450.260.555 D03.633.100.150.266.450.260.555
|
Concept/Terms |
Luteolin- Luteolin
- 3',4',5,7-Tetrahydroxy-Flavone
- 3',4',5,7-Tetrahydroxyflavone
- Luteoline
|
Below are MeSH descriptors whose meaning is more general than "Luteolin".
Below are MeSH descriptors whose meaning is more specific than "Luteolin".
This graph shows the total number of publications written about "Luteolin" by people in this website by year, and whether "Luteolin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2017 | 1 | 2 | 3 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Luteolin" by people in Profiles.
-
Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking. Bioengineered. 2021 12; 12(1):2274-2287.
-
Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics. J Mol Model. 2021 Jul 08; 27(8):221.
-
Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results. Eur Rev Med Pharmacol Sci. 2021 06; 25(11):4156-4162.
-
Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study. Arch Microbiol. 2021 Aug; 203(6):3557-3564.
-
Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors. 2021 Mar; 47(2):232-241.
-
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6. Biosci Rep. 2021 01 29; 41(1).
-
COVID-19, microthromboses, inflammation, and platelet activating factor. Biofactors. 2020 Nov; 46(6):927-933.
-
Potential association of mast cells with coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021 03; 126(3):217-218.
-
Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors. 2021 Mar; 47(2):190-197.
-
COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome? J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1633-1636.